A record review was performed.A product deficiency review was performed and there is no product deficiency identified.A document, service history, and trending was reviewed.There is not a recognizable adverse trend.The risks and mitigations associated with the complaint issue are identified in existing risk documents and no new risks were identified as part of this investigation.A labeling review was conducted; the operator manual for the system was reviewed and found to include adequate instructions for use, warnings and operational errors.The review of the device history record (dhr) for femtosecond laser system showed that there were no issues or non-conformities.The system and its components met all specifications prior to being released.Manufacturing has been ruled out as a potential cause for the reported issue.Based on the investigation results, no corrective action has been issued.Based on the investigation results there is no indication of a product quality deficiency.Johnson & johnson surgical vision will continue to monitor this type of complaints.All pertinent information available to johnson & johnson surgical vision, inc has been submitted.
|
It was reported that a laser vision correction patient had surgery on (b)(6) 2020 and presented on (b)(6) 2020 with inflammation in both eyes (ou), post treatment.Medrol dose pack, an oral steroid was prescribed and the topical steroid dosage was increased.A flap lift and rinse was also performed.It was stated that the patient had no loss of best corrected visual acuity (bcva).The patient had no complaints.Patient reported symptoms are not interfering with daily activities.
|